Clinical Trial Update: Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating thymoquinone plus metformin for PCOS-related disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Thymoquinone (thymoquinone)
• metformin (metformin)

Snippet

Sponsor: Saudi German Hospital - Madinah | Conditions: Polycystic Ovary Syndrome (PCOS) | Phase 2, Phase 3 | Status: COMPLETED